Table 2.
Effects of Lipofundin on redox biomarkers. Values represent the mean ± standard deviation. Asterisks represent statistical differences (P < 0.05). The concentration of aortic parameters is expressed per milligrams of total proteins (Pr).
| Control | Lipofundin | |
|---|---|---|
| Systemic redox biomarkers | ||
|
| ||
| MDA, μM | 2.69 ± 0.07 | 6.24 ± 0.28* |
| AOPP, μM of chloramines | 11.50 ± 0.73 | 16.22 ± 0.47* |
| PP, μM of MDA | 4.63 ± 0.18 | 9.13 ± 0.34* |
| CAT, U/L/min | 351.13 ± 19.03 | 477.50 ± 30.46* |
| SOD, U/mL/min | 22.03 ± 26.44 | 32.00 ± 1.60* |
| NO2, μM | 179.18 ± 11.44 | 134.33 ± 5.09* |
| GSH, μM | 309.03 ± 26.44 | 191.21 ± 8.26* |
|
| ||
| Aortic redox biomarkers | ||
|
| ||
| MDA, μM/mgPr | 18.49 ± 2.04 | 27.42 ± 2.55* |
| AOPP, μM of chloramines/mgPr | 12.45 ± 1.21 | 24.25 ± 1.86* |
| PP, μM of MDA/mgPr | 13.81 ± 1.83 | 25.26 ± 2.29* |
| CAT, U/L/min/mgPr | 1023.60 ± 26.89 | 1609.68 ± 84.37* |
| SOD, U/mL/min/mgPr | 62.37 ± 3.93 | 105.39 ± 9.82* |
| NO2, μM/mgPr | 95.29 ± 2.54 | 43.96 ± 6.03* |
| GSH, μM/mgPr | 166.70 ± 12.82 | 71.59 ± 10.89* |